Common Stock, Shares, Outstanding of Astria Therapeutics, Inc. from 31 Dec 2014 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Astria Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2014 to 30 Sep 2025.
  • Astria Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 56,434,894, a 0% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Astria Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 56,434,894 +675 +0% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 56,434,219 +1,513,556 +2.8% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 56,434,219 +1,531,158 +2.8% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 56,434,219 +15,399,422 +38% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 56,434,219 +28,391,923 +101% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 54,920,663 +26,894,819 +96% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 54,903,061 +26,916,343 +96% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 41,034,797 +13,533,457 +49% 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 28,042,296 +15,025,341 +115% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 28,025,844 +15,008,889 +115% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 27,986,718 +14,969,763 +115% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 27,501,340 +14,484,385 +111% 31 Dec 2022 10-K 04 Mar 2024 2023 FY
Q3 2022 13,016,955 +7,478 +0.06% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 13,016,955 -63,931,848 -83% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 13,016,955 -10,400,051 -44% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 13,016,955 +9,669,569 +289% 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q3 2021 13,009,477 -7,067,860 -35% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 76,948,803 +58,125,202 +309% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 23,417,006 +5,519,834 +31% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 3,347,386 -9,086,214 -73% 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q3 2020 20,077,337 +8,362,051 +71% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 18,823,601 +7,269,664 +63% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 17,897,172 +6,400,930 +56% 31 Mar 2020 10-Q 12 May 2020 2020 Q1
Q4 2019 12,433,600 +5,291,604 +74% 31 Dec 2019 10-K/A 19 Apr 2021 2020 FY
Q3 2019 11,715,286 -59,323,133 -84% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 11,553,937 -59,484,482 -84% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 11,496,242 -17,539,260 -60% 31 Mar 2019 10-Q 14 May 2019 2019 Q1
Q4 2018 7,141,996 +4,777,470 +202% 31 Dec 2018 10-K 10 Mar 2020 2019 FY
Q3 2018 71,038,419 +48,143,386 +210% 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 71,038,419 +48,556,684 +216% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 29,035,502 +9,038,305 +45% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 2,364,526 -16,453,046 -87% 31 Dec 2017 10-K 14 Mar 2019 2018 FY
Q3 2017 22,895,033 +4,255,748 +23% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 22,481,735 +7,100,317 +46% 30 Jun 2017 10-Q 10 Aug 2017 2017 Q2
Q1 2017 19,997,197 +4,635,209 +30% 31 Mar 2017 10-Q 11 May 2017 2017 Q1
Q4 2016 18,817,572 +3,504,275 +23% 31 Dec 2016 10-K 15 Mar 2018 2017 FY
Q3 2016 18,639,285 30 Sep 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 15,381,418 +83,624 +0.55% 30 Jun 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 15,361,988 31 Mar 2016 10-Q 12 May 2016 2016 Q1
Q4 2015 15,313,297 +14,820,097 +3005% 31 Dec 2015 10-K 16 Mar 2017 2016 FY
Q2 2015 15,297,794 30 Jun 2015 10-Q 13 Aug 2015 2015 Q2
Q4 2014 493,200 31 Dec 2014 10-K 15 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.